Artiva Biotherapeutics (NASDAQ:ARTV) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Artiva Biotherapeutics (ARTV) operate in?

Artiva Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Artiva Biotherapeutics Stock (NASDAQ: ARTV) stock price, news, charts, stock research, profile.

Open	$11.06
Close	$11.20
Volume / Avg.	36.76K / 134.13K
Day Range	$10.79 - $11.98
52 Wk Range	9.68 - 17.31
Market Cap	$272.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	3.76%
Days to Cover	12.18

Recent News

Artiva Biotherapeutics' Investigational Scalable Cell Therapies For Autoimmune Disorders, Analyst Initiate With Bullish Pitch

Artiva Biotherapeutics raised $167 million in its July IPO to advance its innovative cell therapies for autoimmune diseases and cancers. Lead candidate AlloNK, in clinical trials for lupus, is projected to drive significant revenue by 2038.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$11.06
Close	$11.20
Volume / Avg.	36.76K / 134.13K
Day Range	$10.79 - $11.98
52 Wk Range	9.68 - 17.31
Market Cap	$272.04M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	3.76%
Days to Cover	12.18

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Artiva Biotherapeutics (ARTV) stock?

You can purchase shares of Artiva Biotherapeutics (NASDAQ:ARTV) through any online brokerage.

View our list of the best stock brokerages

Who are Artiva Biotherapeutics (ARTV) competitors?

Other companies in Artiva Biotherapeutics’s space includes: Precigen (NASDAQ:PGEN), Voyager Therapeutics (NASDAQ:VYGR), Zentalis Pharma (NASDAQ:ZNTL), Sage Therapeutics (NASDAQ:SAGE) and Fate Therapeutics (NASDAQ:FATE).

What is the forecast, or price target, for Artiva Biotherapeutics (ARTV) stock?

Artiva Biotherapeutics has a consensus price target of $21.25.

What is the current price for Artiva Biotherapeutics (ARTV)?

The stock price for Artiva Biotherapeutics (NASDAQ: ARTV) is $11.2 last updated November 22, 2024 at 4:01 PM EST.

Does Artiva Biotherapeutics (ARTV) pay a dividend?

There are no upcoming dividends for Artiva Biotherapeutics.

When is Artiva Biotherapeutics (NASDAQ:ARTV) reporting earnings?

Artiva Biotherapeutics’s Q4 earnings are confirmed for Saturday, February 22, 2025.

Is Artiva Biotherapeutics (ARTV) going to split?

There is no upcoming split for Artiva Biotherapeutics.

What sector and industry does Artiva Biotherapeutics (ARTV) operate in?

Artiva Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Artiva Biotherapeutics

Artiva Biotherapeutics (ARTV) Forecast